Abstract
We describe 10 females with ornithine transcarbamylase (OTC) deficiency and liver dysfunction, revealing a unique pattern of hepatocyte injury in which initial hyperammonemia and coagulopathy is followed by a delayed peak in aminotransferase levels. None of the patients required urgent liver transplantation, though five eventually underwent transplant for recurrent metabolic crises. We intend that this novel observation will initiate further investigations into the pathophysiology of liver dysfunction in OTC-deficient patients, and ultimately lead to the development of therapies and prevent the need for liver transplant.
Keywords:
acute liver dysfunction; female manifestation of OTC deficiency; hepatic lyonization; hyperammonemia; ornithine transcarbamylase.
© 2020 Wiley Periodicals LLC.
MeSH terms
-
Age of Onset
-
Alanine Transaminase / blood*
-
Amino Acid Substitution
-
Aspartate Aminotransferases / blood
-
Biomarkers
-
Child, Preschool
-
Combined Modality Therapy
-
Developmental Disabilities / genetics
-
Disease Progression
-
Female
-
Hemorrhagic Disorders / etiology
-
Humans
-
Hyperammonemia / genetics
-
Infant
-
International Normalized Ratio
-
Liver Diseases / blood
-
Liver Diseases / etiology*
-
Liver Diseases / surgery
-
Liver Transplantation
-
Mutation, Missense
-
Ornithine Carbamoyltransferase Deficiency Disease / blood
-
Ornithine Carbamoyltransferase Deficiency Disease / complications*
-
Ornithine Carbamoyltransferase Deficiency Disease / diet therapy
-
Ornithine Carbamoyltransferase Deficiency Disease / surgery
-
Vomiting / genetics
Substances
-
Biomarkers
-
Aspartate Aminotransferases
-
Alanine Transaminase